PDB Short entry for 1MD7 HEADER HYDROLASE 07-AUG-02 1MD7 TITLE MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R CAVEAT 1MD7 NAG A 1001 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: C1R COMPLEMENT SERINE PROTEASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL CCP-SP DOMAIN; COMPND 5 SYNONYM: COMPLEMENT C1R COMPONENT; COMPND 6 EC: 3.4.21.41; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVETM; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PNT-BAC KEYWDS COMPLEMENT, INNATE IMMUNITY, SERINE PROTEASE, ACTIVATION, SUBSTRATE KEYWDS 2 SPECIFICITY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.BUDAYOVA-SPANO,W.GRABARSE,N.M.THIELENS,H.HILLEN,M.LACROIX, AUTHOR 2 M.SCHMIDT,J.FONTECILLA-CAMPS,G.J.ARLAUD,C.GABORIAUD REVDAT 4 10-NOV-21 1MD7 1 REMARK SEQADV HETSYN REVDAT 3 29-JUL-20 1MD7 1 CAVEAT COMPND REMARK HET REVDAT 3 2 1 HETNAM LINK SITE ATOM REVDAT 2 24-FEB-09 1MD7 1 VERSN REVDAT 1 07-AUG-03 1MD7 0 JRNL AUTH M.BUDAYOVA-SPANO,W.GRABARSE,N.M.THIELENS,H.HILLEN,M.LACROIX, JRNL AUTH 2 M.SCHMIDT,J.FONTECILLA-CAMPS,G.J.ARLAUD,C.GABORIAUD JRNL TITL MONOMERIC STRUCTURES OF THE ZYMOGEN AND ACTIVE CATALYTIC JRNL TITL 2 DOMAIN OF COMPLEMENT PROTEASE C1R: FURTHER INSIGHTS INTO THE JRNL TITL 3 C1 ACTIVATION MECHANISM JRNL REF STRUCTURE V. 10 1509 2002 JRNL REFN ISSN 0969-2126 JRNL PMID 12429092 JRNL DOI 10.1016/S0969-2126(02)00881-X REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1854719.210 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 10900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 568 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1639 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 94 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.033 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2400 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.68000 REMARK 3 B22 (A**2) : 2.68000 REMARK 3 B33 (A**2) : -5.36000 REMARK 3 B12 (A**2) : 10.90000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.46 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.990 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 6.960 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 11.490; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.820 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.830 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.23 REMARK 3 BSOL : 10.46 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MD7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1000016830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-OCT-00 REMARK 200 TEMPERATURE (KELVIN) : 77 REMARK 200 PH : 8.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.964 REMARK 200 MONOCHROMATOR : SI (111) MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11104 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, TAPS, PH 8.4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 14.54933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.09867 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 14.54933 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 29.09867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 399 REMARK 465 ALA A 400 REMARK 465 GLY A 401 REMARK 465 SER A 402 REMARK 465 ARG A 403 REMARK 465 GLU A 404 REMARK 465 SER A 405 REMARK 465 GLU A 406 REMARK 465 GLN A 443 REMARK 465 ARG A 444 REMARK 465 GLN A 445 REMARK 465 ARG A 446 REMARK 465 VAL A 581 REMARK 465 MET A 582 REMARK 465 GLU A 583 REMARK 465 GLU A 584 REMARK 465 LYS A 585 REMARK 465 ILE A 586 REMARK 465 ARG A 608 REMARK 465 GLY A 609 REMARK 465 LYS A 610 REMARK 465 ASN A 611 REMARK 465 ARG A 612 REMARK 465 MET A 613 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 407 CG CD OE1 NE2 REMARK 480 GLU A 421 CG CD OE1 OE2 REMARK 480 GLN A 422 CG CD OE1 NE2 REMARK 480 LYS A 423 CB NZ REMARK 480 GLU A 491 CB CG CD OE1 OE2 REMARK 480 LYS A 629 CG CD CE NZ REMARK 480 ASN A 647 CB CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 359 -137.37 -74.86 REMARK 500 ASP A 369 -157.55 -149.64 REMARK 500 THR A 375 125.74 -36.17 REMARK 500 ASN A 379 34.61 -85.81 REMARK 500 TYR A 381 144.55 -30.91 REMARK 500 LYS A 382 -5.58 73.07 REMARK 500 CYS A 412 93.86 -54.24 REMARK 500 GLU A 421 17.74 -44.86 REMARK 500 GLN A 422 -47.43 -131.05 REMARK 500 GLU A 425 -19.04 81.28 REMARK 500 PRO A 428 -179.84 -63.43 REMARK 500 LYS A 436 68.13 -176.32 REMARK 500 ASN A 439 59.18 -160.59 REMARK 500 PRO A 440 -163.63 -66.88 REMARK 500 GLN A 451 -162.16 -103.34 REMARK 500 MET A 455 110.56 -36.81 REMARK 500 ASN A 465 66.30 -159.59 REMARK 500 ILE A 466 -92.03 -90.64 REMARK 500 HIS A 467 62.58 -104.55 REMARK 500 ARG A 478 42.64 -152.69 REMARK 500 GLU A 491 158.30 -46.22 REMARK 500 ALA A 498 93.96 -178.44 REMARK 500 HIS A 506 172.20 176.85 REMARK 500 ASP A 563 -16.32 -145.76 REMARK 500 TYR A 568 51.76 -105.51 REMARK 500 PRO A 600 -18.03 -48.77 REMARK 500 ALA A 623 137.84 -177.37 REMARK 500 PRO A 626 -11.03 -49.54 REMARK 500 LYS A 629 -140.69 65.68 REMARK 500 ALA A 637 121.18 154.69 REMARK 500 ARG A 650 -134.62 -104.17 REMARK 500 TRP A 651 116.10 -172.67 REMARK 500 SER A 658 -153.64 -103.01 REMARK 500 ILE A 661 -32.76 -130.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GPZ RELATED DB: PDB REMARK 900 1GPZ CONTAINS THE SAME PROTEIN, IN THE SAME ZYMOGEN STATE, A LONGER REMARK 900 FRAGMENT(CCP1-CCP2-SP), A DIMERIC ASSEMBLY REMARK 900 RELATED ID: 1MD8 RELATED DB: PDB REMARK 900 1MD8 CONTAINS THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R DBREF 1MD7 A 358 685 UNP P00736 C1R_HUMAN 375 702 SEQADV 1MD7 ALA A 637 UNP P00736 SER 654 ENGINEERED MUTATION SEQRES 1 A 328 ASP CYS GLY GLN PRO ARG ASN LEU PRO ASN GLY ASP PHE SEQRES 2 A 328 ARG TYR THR THR THR MET GLY VAL ASN THR TYR LYS ALA SEQRES 3 A 328 ARG ILE GLN TYR TYR CYS HIS GLU PRO TYR TYR LYS MET SEQRES 4 A 328 GLN THR ARG ALA GLY SER ARG GLU SER GLU GLN GLY VAL SEQRES 5 A 328 TYR THR CYS THR ALA GLN GLY ILE TRP LYS ASN GLU GLN SEQRES 6 A 328 LYS GLY GLU LYS ILE PRO ARG CYS LEU PRO VAL CYS GLY SEQRES 7 A 328 LYS PRO VAL ASN PRO VAL GLU GLN ARG GLN ARG ILE ILE SEQRES 8 A 328 GLY GLY GLN LYS ALA LYS MET GLY ASN PHE PRO TRP GLN SEQRES 9 A 328 VAL PHE THR ASN ILE HIS GLY ARG GLY GLY GLY ALA LEU SEQRES 10 A 328 LEU GLY ASP ARG TRP ILE LEU THR ALA ALA HIS THR LEU SEQRES 11 A 328 TYR PRO LYS GLU HIS GLU ALA GLN SER ASN ALA SER LEU SEQRES 12 A 328 ASP VAL PHE LEU GLY HIS THR ASN VAL GLU GLU LEU MET SEQRES 13 A 328 LYS LEU GLY ASN HIS PRO ILE ARG ARG VAL SER VAL HIS SEQRES 14 A 328 PRO ASP TYR ARG GLN ASP GLU SER TYR ASN PHE GLU GLY SEQRES 15 A 328 ASP ILE ALA LEU LEU GLU LEU GLU ASN SER VAL THR LEU SEQRES 16 A 328 GLY PRO ASN LEU LEU PRO ILE CYS LEU PRO ASP ASN ASP SEQRES 17 A 328 THR PHE TYR ASP LEU GLY LEU MET GLY TYR VAL SER GLY SEQRES 18 A 328 PHE GLY VAL MET GLU GLU LYS ILE ALA HIS ASP LEU ARG SEQRES 19 A 328 PHE VAL ARG LEU PRO VAL ALA ASN PRO GLN ALA CYS GLU SEQRES 20 A 328 ASN TRP LEU ARG GLY LYS ASN ARG MET ASP VAL PHE SER SEQRES 21 A 328 GLN ASN MET PHE CYS ALA GLY HIS PRO SER LEU LYS GLN SEQRES 22 A 328 ASP ALA CYS GLN GLY ASP ALA GLY GLY VAL PHE ALA VAL SEQRES 23 A 328 ARG ASP PRO ASN THR ASP ARG TRP VAL ALA THR GLY ILE SEQRES 24 A 328 VAL SER TRP GLY ILE GLY CYS SER ARG GLY TYR GLY PHE SEQRES 25 A 328 TYR THR LYS VAL LEU ASN TYR VAL ASP TRP ILE LYS LYS SEQRES 26 A 328 GLU MET GLU MODRES 1MD7 ASN A 497 ASN GLYCOSYLATION SITE HET NAG A1001 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 HOH *117(H2 O) HELIX 1 1 ALA A 483 TYR A 488 5 6 HELIX 2 2 ASN A 508 GLY A 516 1 9 HELIX 3 3 ASN A 564 TYR A 568 5 5 HELIX 4 4 LEU A 628 GLN A 634 5 7 HELIX 5 5 TYR A 676 GLU A 685 1 10 SHEET 1 A 4 GLY A 368 TYR A 372 0 SHEET 2 A 4 ARG A 384 CYS A 389 -1 O GLN A 386 N ARG A 371 SHEET 3 A 4 VAL A 409 CYS A 412 -1 O TYR A 410 N ILE A 385 SHEET 4 A 4 TRP A 418 LYS A 419 -1 O LYS A 419 N THR A 411 SHEET 1 B 2 TYR A 394 MET A 396 0 SHEET 2 B 2 CYS A 430 PRO A 432 -1 O LEU A 431 N LYS A 395 SHEET 1 C 6 VAL A 502 LEU A 504 0 SHEET 2 C 6 GLN A 461 ASN A 465 -1 N PHE A 463 O PHE A 503 SHEET 3 C 6 ARG A 469 LEU A 475 -1 O GLY A 472 N VAL A 462 SHEET 4 C 6 TRP A 479 THR A 482 -1 O LEU A 481 N ALA A 473 SHEET 5 C 6 ALA A 542 LEU A 546 -1 O ALA A 542 N THR A 482 SHEET 6 C 6 ILE A 520 VAL A 525 -1 N SER A 524 O LEU A 543 SHEET 1 D 6 ARG A 591 PRO A 596 0 SHEET 2 D 6 MET A 573 GLY A 578 -1 N VAL A 576 O VAL A 593 SHEET 3 D 6 PHE A 641 VAL A 643 -1 O ALA A 642 N TYR A 575 SHEET 4 D 6 VAL A 652 VAL A 657 -1 O THR A 654 N PHE A 641 SHEET 5 D 6 TYR A 667 LYS A 672 -1 O THR A 671 N ILE A 656 SHEET 6 D 6 MET A 620 GLY A 624 -1 N PHE A 621 O TYR A 670 SSBOND 1 CYS A 359 CYS A 412 1555 1555 2.03 SSBOND 2 CYS A 389 CYS A 430 1555 1555 2.04 SSBOND 3 CYS A 434 CYS A 560 1555 1555 2.04 SSBOND 4 CYS A 603 CYS A 622 1555 1555 2.04 SSBOND 5 CYS A 633 CYS A 663 1555 1555 2.03 LINK ND2 ASN A 497 C1 NAG A1001 1555 1555 1.46 CISPEP 1 GLU A 391 PRO A 392 0 -0.08 CRYST1 167.060 167.060 43.648 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005986 0.003456 0.000000 0.00000 SCALE2 0.000000 0.006912 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022910 0.00000